{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "A direct interaction between ATXN3 and Promyelocytic leukemia protein (PML) was shown via co-immunoprecipitation (Co-IP).",
  "functions": [
    {
      "function": "Inhibition of Deubiquitinase Activity",
      "arrow": "activates",
      "cellular_process": "The Promyelocytic leukemia protein isoform II (PML-II) specifically interacts with ATXN3 via its unique C-terminal region. This interaction recruits ATXN3 into PML nuclear bodies (NBs), subnuclear structures involved in various cellular processes. The sequestration and localization of ATXN3 within these bodies leads to the inhibition of its deubiquitinase (DUB) activity.",
      "effect_description": "The recruitment of ATXN3 to PML-NBs by PML-II serves as a negative regulatory mechanism, suppressing the enzymatic function of ATXN3. This suggests that PML-NBs act as hubs for controlling the activity of nuclear ATXN3, thereby influencing the stability of its protein substrates.",
      "biological_consequence": [
        "The C-terminal domain of PML-II binds directly to ATXN3 → ATXN3 is recruited from the nucleoplasm into PML nuclear bodies → The deubiquitinase activity of ATXN3 is inhibited → The removal of ubiquitin chains from ATXN3 substrates is reduced → The stability and turnover of ATXN3 target proteins are altered."
      ],
      "specific_effects": [
        "The interaction is specific to the PML-II isoform and does not occur with the C-terminal regions of other PML isoforms.",
        "PML-II binds to both wild-type ATXN3 (13Q) and the pathological, polyQ-expanded form (79Q).",
        "Co-immunoprecipitation assays and immunofluorescent microscopy confirmed a direct interaction and co-localization of PML-II and ATXN3 within PML-NBs."
      ],
      "evidence": [
        {
          "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
          "journal": "Biochemical and Biophysical Research Communications",
          "year": 2021,
          "relevant_quote": "Here, we report the characterization of the deubiquitinase ataxin-3 as a specific binding partner of PML isoform II (PML-II). Ataxin-3 only binds to the C-terminal region of PML-II and not that of other PML isoforms... Importantly, the deubiquitinase activity of ataxin-3 was inhibited by PML-II. Our results suggest that PML-II may be a negative regulator of ataxin-3.",
          "pmid": "33798946"
        }
      ],
      "pathway": {
        "name": "Ubiquitin-Proteasome System",
        "canonical_name": "Proteasomal Degradation",
        "ontology_id": "GO:0010498",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "33798946"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "The Promyelocytic leukemia protein isoform II (PML-II) specifically interacts with ATXN3 via its unique C-terminal region. This interaction recruits ATXN3 into PML nuclear bodies (NBs), subnuclear structures involved in various cellular processes. The sequestration and localization of ATXN3 within these bodies leads to the inhibition of its deubiquitinase (DUB) activity.",
  "effect": "The recruitment of ATXN3 to PML-NBs by PML-II serves as a negative regulatory mechanism, suppressing the enzymatic function of ATXN3. This suggests that PML-NBs act as hubs for controlling the activity of nuclear ATXN3, thereby influencing the stability of its protein substrates.",
  "summary": "ATXN3 inhibits PML to modulate inhibition of deubiquitinase activity, ultimately affecting the stability and turnover of atxn3 target proteins are altered.",
  "evidence": [
    {
      "paper_title": "PML-II recruits ataxin-3 to PML-NBs and inhibits its deubiquitinating activity",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2021,
      "relevant_quote": "Here, we report the characterization of the deubiquitinase ataxin-3 as a specific binding partner of PML isoform II (PML-II). Ataxin-3 only binds to the C-terminal region of PML-II and not that of other PML isoforms... Importantly, the deubiquitinase activity of ataxin-3 was inhibited by PML-II. Our results suggest that PML-II may be a negative regulator of ataxin-3."
    }
  ],
  "pathways": [
    {
      "name": "Ubiquitin-Proteasome System",
      "canonical_name": "Proteasomal Degradation",
      "ontology_id": "GO:0010498",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- PML:",
  "protein_a": "PML",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.499215Z",
  "last_updated": "2025-12-07T22:39:21.499215Z"
}